Patents by Inventor Robert J. Przybelski

Robert J. Przybelski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of hemoglobin in the treatment of hypotension
    Patent number: 6117838
    Abstract: A method of treating a mammal suffering from hypotension by administering intermolecularly- or intramolecularly-crosslinked stroma-free hemoglobin to the mammal.
    Type: Grant
    Filed: June 2, 1998
    Date of Patent: September 12, 2000
    Assignee: Baxter International, Inc.
    Inventor: Robert J. Przybelski
  • Hemoglobin therapy in hemodialysis
    Patent number: 6114303
    Abstract: Low doses of stroma-free diaspirin cross-linked hemoglobin are administered to patients undergoing hemodialysis, to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Hemoglobin therapy when implemented prophylactically in hemodialysis also partially obviates the need for further interventions to control circulatory system instability.
    Type: Grant
    Filed: May 3, 1999
    Date of Patent: September 5, 2000
    Assignee: Baxter International, Inc.
    Inventors: John Blue, Jan W. Garber, Janet C. Gonder, Gary R. Marchand, Robert J. Przybelski, Kathleen N. Stern
  • Use of hemoglobin to treat septic shock
    Patent number: 6090779
    Abstract: Therapeutic treatment of septic shock comprises administering to an animal stroma-free hemoglobin, typically at a dose ranging from the least amount effective to increase perfusion, up to a dosage of about 2500 milligrams kilograms per of body weight.
    Type: Grant
    Filed: March 18, 1997
    Date of Patent: July 18, 2000
    Assignee: Baxter International, Inc.
    Inventors: Robert J. Przybelski, Kenneth E. Burhop
  • Use of hemoglobin in the treatment of cardiogenic shock
    Patent number: 6046161
    Abstract: A method for increasing perfusion in a mammal suffering from cardiogenic shock by administering a perfusion-increasing effective amount of intermolecularly- or intramolecularly-crosslinked stroma-free hemoglobin to the mammal.
    Type: Grant
    Filed: February 27, 1998
    Date of Patent: April 4, 2000
    Assignee: Baxter International, Inc.
    Inventor: Robert J. Przybelski
  • Use of hemoglobin in the treatment of stroke
    Patent number: 6022850
    Abstract: A method for increasing perfusion in a mammal suffering from stroke by admninistering a perfusion-increasing effective amount of intermolecularly- or intramolecularly-crosslinked stroma-free hemoglobin to the mammal.
    Type: Grant
    Filed: February 27, 1998
    Date of Patent: February 8, 2000
    Assignee: Baxter International, Inc.
    Inventor: Robert J. Przybelski
  • Use of hemoglobin to treat systemic inflammatory response syndrome
    Patent number: 5970985
    Abstract: A method for treating systemic inflammatory response syndrome in a mammal by administering to the mammal a hemoglobin preparation after the mammal is diagnosed as suffering from systemic inflammatory response syndrome, wherein the systemic inflammatory response syndrome is a condition other than sepsis.
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: October 26, 1999
    Assignee: Baxter International, Inc.
    Inventors: Kenneth E. Burhop, Robert J. Przybelski
  • Hemoglobin therapy in hemodialysis
    Patent number: 5906974
    Abstract: Low doses of stroma-free diaspirin cross-linked hemoglobin are administered to patients undergoing hemodialysis, to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Hemoglobin therapy when implemented prophylactically in hemodialysis also partially obviates the need for further interventions to control circulatory system instability.
    Type: Grant
    Filed: August 21, 1996
    Date of Patent: May 25, 1999
    Assignee: Baxter International, Inc.
    Inventors: John Blue, Jan W. Garber, Janet C. Gonder, Gary R. Marchand, Robert J. Przybelski, Kathleen N. Stern
  • Use of hemoglobin in the treatment of hemorrhagic shock
    Patent number: 5900477
    Abstract: A method of treating a mammal suffering from hemorrhagic shock or reducing hypotension secondary to hemorrhagic shock in a mammal suffering from hemorrhagic shock by administering intermolecularly- or intramolecularly-crosslinked stroma-free hemoglobin to the mammal.
    Type: Grant
    Filed: February 27, 1998
    Date of Patent: May 4, 1999
    Assignee: Baxter International, Inc.
    Inventor: Robert J. Przybelski
  • Administration of low dose hemoglobin to increase perfusion
    Patent number: 5614490
    Abstract: This invention provides a method to therapeutically increase perfusion in a mammal comprising administering stroma-free hemoglobin at a dose ranging from the least amount effective to increase perfusion, up to a dose of about 2500 mg per kilogram of body weight.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 25, 1997
    Assignee: Baxter Healthcare Corporation
    Inventor: Robert J. Przybelski
  • Administration of low dose hemoglobin to increase perfusion
    Patent number: 5510464
    Abstract: This invention provides a method to therapeutically increase perfusion in a mammal comprising administering stroma-free hemoglobin at a dose ranging from the least amount effective to increase perfusion, up to a dose of about 2500 mg per kilogram of body weight.
    Type: Grant
    Filed: May 3, 1994
    Date of Patent: April 23, 1996
    Assignee: Baxter International Inc.
    Inventor: Robert J. Przybelski
  • Administration of low dose hemoglobin to increase perfusion
    Patent number: 5334706
    Abstract: This invention provides a method to therapeutically increase perfusion in a mammal comprising administering stroma-free hemoglobin at a dose ranging from the least amount effective to increase perfusion, up to a dose of about 2500 mg per kilogram of body weight.
    Type: Grant
    Filed: January 30, 1992
    Date of Patent: August 2, 1994
    Assignee: Baxter International
    Inventor: Robert J. Przybelski